We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Report Iran - Human Blood and Animal Blood Prepared for Therapeutic, Pophylactic or Diagnostic Uses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

Iran - Human Blood and Animal Blood Prepared for Therapeutic, Pophylactic or Diagnostic Uses - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
What's the difference?
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Iran: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Iran

In 2021, after nine years of growth, there was significant decline in the Iranian human and animal blood market, when its value decreased by -19.6% to $X. Over the period under review, consumption, however, enjoyed prominent growth. As a result, consumption attained the peak level of $X, and then contracted dramatically in the following year.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Iran

In value terms, human and animal blood production shrank notably to $X in 2021 estimated in export price. Overall, production, however, continues to indicate a significant increase. The most prominent rate of growth was recorded in 2020 with an increase of 56%. As a result, production reached the peak level of $X, and then contracted markedly in the following year.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports from Iran

In 2021, after four years of decline, there was significant growth in overseas shipments of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, when their volume increased by 11,596% to X tons. Over the period under review, exports showed significant growth. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

In value terms, human and animal blood exports skyrocketed to $X in 2021. In general, exports saw a significant increase. The most prominent rate of growth was recorded in 2015 when exports increased by 1,077% against the previous year. The exports peaked at $X in 2019; however, from 2020 to 2021, the exports remained at a lower figure.

Exports by Country

Slovenia (X tons) was the main destination for human and animal blood exports from Iran, with a approx. 97% share of total exports.

From 2012 to 2021, the average annual rate of growth in terms of volume to Slovenia stood at +853.2%.

In value terms, Slovenia ($X) also remains the key foreign market for human and animal blood exports from Iran.

From 2012 to 2021, the average annual rate of growth in terms of value to Slovenia stood at +364.7%.

Export Prices by Country

The average human and animal blood export price stood at $X per ton in 2021, with a decrease of -95.7% against the previous year. Over the period under review, the export price, however, saw a resilient increase. The growth pace was the most rapid in 2018 an increase of 211%. The export price peaked at $X per ton in 2020, and then fell remarkably in the following year.

As there is only one major export destination, the average price level is determined by prices for Slovenia.

From 2012 to 2021, the rate of growth in terms of prices for Switzerland amounted to +133.3% per year.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports into Iran

In 2021, purchases abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses increased by 7.5% to X tons for the first time since 2018, thus ending a two-year declining trend. In general, imports continue to indicate buoyant growth. The pace of growth was the most pronounced in 2016 when imports increased by 167% against the previous year. Imports peaked at X tons in 2018; however, from 2019 to 2021, imports remained at a lower figure.

In value terms, human and animal blood imports skyrocketed to $X in 2021. Overall, imports showed a tangible increase. The growth pace was the most rapid in 2016 with an increase of 272% against the previous year. Imports peaked at $X in 2017; however, from 2018 to 2021, imports failed to regain momentum.

Imports by Country

In 2021, Turkey (X tons) constituted the largest supplier of human and animal blood to Iran, with a 45% share of total imports. Moreover, human and animal blood imports from Turkey exceeded the figures recorded by the second-largest supplier, Denmark (X tons), twofold. The third position in this ranking was taken by Switzerland (X tons), with a 13% share.

From 2012 to 2021, the average annual growth rate of volume from Turkey amounted to +54.3%. The remaining supplying countries recorded the following average annual rates of imports growth: Denmark (+7.0% per year) and Switzerland (+15.1% per year).

In value terms, Denmark ($X), South Korea ($X) and Turkey ($X) appeared to be the largest human and animal blood suppliers to Iran, together comprising 74% of total imports.

Turkey, with a CAGR of +52.9%, saw the highest growth rate of the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average human and animal blood import price stood at $X per ton in 2021, rising by 9% against the previous year. In general, the import price, however, showed a pronounced curtailment. The most prominent rate of growth was recorded in 2016 when the average import price increased by 39% against the previous year. Over the period under review, average import prices attained the peak figure at $X per ton in 2012; however, from 2013 to 2021, import prices stood at a somewhat lower figure.

Prices varied noticeably country of origin: the country with the highest price was South Korea ($X per ton), while the price for Switzerland ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by South Korea (+19.6%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

The countries with the highest volumes of in 2021 were the United States, China and India, with a combined 52% share of global consumption. Brazil, Russia, the UK, France, Japan, Iran, Spain, South Korea and Thailand lagged somewhat behind, together accounting for a further 27%.
The countries with the highest volumes of in 2021 were the United States, China and India, with a combined 59% share of global production. These countries were followed by Russia, Brazil, the UK, France, Japan, Iran, South Korea, Spain, Denmark and Thailand, which together accounted for a further 29%.
In value terms, the largest human and animal blood suppliers to Iran were Denmark, Turkey and Italy, together accounting for 78% of total imports.
In value terms, Slovenia remains the key foreign market for human and animal blood exports from Iran.
The average human and animal blood export price stood at $10,303 per ton in 2021, which is down by -95.2% against the previous year.
In 2021, the average human and animal blood import price amounted to $240,292 per ton, increasing by 9% against the previous year.

This report provides an in-depth analysis of the market for human and animal blood in Iran. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21106055 - Human blood, animal blood prepared for therapeutic, p rophylactic or diagnostic uses, cultures of micro-organisms, t oxins (excluding yeasts)

Country coverage:

  • Iran

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in Iran
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS

  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO

  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030

  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT

  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES

  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS

  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE

  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY

  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY

  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO

  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023

  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023

Recommended reports

World - Human Blood and Animal Blood Prepared for Therapeutic, Pophylactic or Diagnostic Uses - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 490

This report provides an in-depth analysis of the global market for human and animal blood.

EU - Human Blood and Animal Blood Prepared for Therapeutic, Pophylactic or Diagnostic Uses - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 337

This report provides an in-depth analysis of the market for human and animal blood in the EU.

Asia - Human Blood and Animal Blood Prepared for Therapeutic, Pophylactic or Diagnostic Uses - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 301

This report provides an in-depth analysis of the market for human and animal blood in Asia.

U.S. - Human Blood and Animal Blood Prepared for Therapeutic, Pophylactic or Diagnostic Uses - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 386

This report provides an in-depth analysis of the market for human and animal blood in the U.S..

China - Human Blood and Animal Blood Prepared for Therapeutic, Pophylactic or Diagnostic Uses - Market Analysis, Forecast, Size, Trends and Insights
$599
Nov 1, 2024
Eye 303

This report provides an in-depth analysis of the market for human and animal blood in China.

Free Data: Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses - Iran
Table
Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses - Iran - Table
Dashboard
Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses - Iran - Dashboard
Report
Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses - Iran - Report